share_log

RBC Capital Reiterates Outperform on Mind Medicine, Maintains $5 Price Target

Benzinga ·  Jun 21, 2023 09:15

RBC Capital analyst Brian Abrahams reiterates Mind Medicine (NASDAQ:MNMD) with a Outperform and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment